Maia Wealth LLC boosted its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 15.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,855 shares of the company’s stock after buying an additional 520 shares during the quarter. Maia Wealth LLC’s holdings in Procter & Gamble were worth $656,000 at the end of the most recent quarter.
Other institutional investors have also recently bought and sold shares of the company. Umpqua Bank lifted its position in Procter & Gamble by 0.9% during the 3rd quarter. Umpqua Bank now owns 17,036 shares of the company’s stock worth $2,951,000 after acquiring an additional 151 shares during the last quarter. Harvest Portfolios Group Inc. lifted its holdings in shares of Procter & Gamble by 2.1% during the 3rd quarter. Harvest Portfolios Group Inc. now owns 110,486 shares of the company’s stock worth $19,136,000 after acquiring an additional 2,285 shares during the period. Foster & Motley Inc. boosted its position in shares of Procter & Gamble by 0.6% during the 3rd quarter. Foster & Motley Inc. now owns 73,925 shares of the company’s stock valued at $12,804,000 after acquiring an additional 436 shares in the last quarter. Benchmark Financial Wealth Advisors LLC increased its holdings in shares of Procter & Gamble by 11.0% during the third quarter. Benchmark Financial Wealth Advisors LLC now owns 1,832 shares of the company’s stock worth $317,000 after buying an additional 182 shares in the last quarter. Finally, Radnor Capital Management LLC acquired a new position in shares of Procter & Gamble during the third quarter valued at $5,705,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
PG traded down $2.67 during midday trading on Wednesday, hitting $163.09. 2,080,342 shares of the company traded hands, compared to its average volume of 6,600,231. The firm has a market capitalization of $384.08 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42. The company’s 50-day moving average is $171.45 and its 200 day moving average is $168.18. The Procter & Gamble Company has a 52 week low of $142.50 and a 52 week high of $177.94. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.47%. The ex-dividend date is Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is currently 69.48%.
Analyst Ratings Changes
A number of research analysts have issued reports on the company. Dbs Bank downgraded Procter & Gamble from a “strong-buy” rating to a “hold” rating in a report on Thursday, August 1st. Stifel Nicolaus lifted their price target on Procter & Gamble from $157.00 to $161.00 and gave the company a “hold” rating in a research note on Monday, July 22nd. DA Davidson increased their price objective on Procter & Gamble from $159.00 to $160.00 and gave the company a “neutral” rating in a report on Monday, October 21st. TD Cowen assumed coverage on Procter & Gamble in a research report on Tuesday, July 23rd. They set a “buy” rating and a $189.00 target price on the stock. Finally, DZ Bank upgraded Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 price target on the stock in a report on Thursday, August 29th. Nine analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $177.00.
Check Out Our Latest Research Report on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, CEO Jon R. Moeller sold 37,240 shares of the business’s stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the completion of the transaction, the chief executive officer now owns 263,537 shares in the company, valued at $44,508,763.93. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other Procter & Gamble news, CFO Andre Schulten sold 13,041 shares of Procter & Gamble stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the completion of the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Jon R. Moeller sold 37,240 shares of the business’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total value of $6,289,463.60. Following the sale, the chief executive officer now owns 263,537 shares of the company’s stock, valued at $44,508,763.93. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 385,771 shares of company stock worth $65,610,975 over the last 90 days. Company insiders own 0.18% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Articles
- Five stocks we like better than Procter & Gamble
- Following Congress Stock Trades
- Macro Headwinds Send Microchip Technology Stock to the Buy Zone
- How to Invest in the Best Canadian StocksĀ
- 3 Rising-Margin Stocks with Strong Growth Potential
- Investing in Commodities: What Are They? How to Invest in Them
- 3 Recession-Resistant Stocks: Low Beta, High Margins, Low Debt
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.